Edwards Lifesciences (EW)
Health Care4 articles
Price chart
Edwards Lifesciences (EW) overview
Edwards Lifesciences specializes in heart-valve and critical-care devices. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
Edwards Lifesciences trades on the NYSE under the ticker symbol EW. As of the most recent market data, the stock was priced around $91.11, up 0.40% on the session, giving Edwards Lifesciences a market capitalization of roughly $52.52B.
Over the past 52 weeks, EW has traded between $72.30 and $96.29. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 54.2, a common gauge of how richly the market prices the company's earnings.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch EW
As one of the larger companies in the Health Care sector, Edwards Lifesciences is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch EW for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
Market Mood
Latest EW news
Edwards Lifesciences Corp (EW) Form 4 Filing on July 30
Edwards Lifesciences Corp (EW) filed a Form 4, an official statement regarding insider transactions, which is scheduled for July 30. This filing typically includes details on the buying or selling of shares by company executives or board members. Such disclosures are essential as they provide transparency regarding insider activities that may influence investor sentiment. Monitoring Form 4 filings helps investors gauge company insiders' confidence in the company’s future performance.
Read More: Edwards Lifesciences Corp (EW) Form 4 Filing on July 30
Edwards Lifesciences Corp (EW) Form 4 Filing on July 27
Edwards Lifesciences Corp (EW) has a Form 4 filing scheduled for July 27. This document will disclose changes in insider ownership, offering insights into stockholder activity. Tracking insider transactions can be essential for investors, as they may indicate expected future performance. The scheduled filing is a key event for stakeholders in the company.
Read More: Edwards Lifesciences Corp (EW) Form 4 Filing on July 27
Edwards Lifesciences CEO Sells $245,134 in Shares
Bernard Zovighian, the CEO of Edwards Lifesciences, sold shares worth $245,134. This sale may raise concerns among investors regarding insider trading patterns and confidence in the company's future performance. Shareholder reaction could influence the stock's performance following this transaction. Understanding the context of insider sales is important for investors to gauge market sentiment about Edwards Lifesciences (EW).
Read More: Edwards Lifesciences CEO Sells $245,134 in Shares
Edwards Lifesciences (EW) CFO Ullem sells $1M in company shares
Edwards Lifesciences (EW) CFO Scott Ullem sold $1 million worth of company shares. This transaction raises questions about insider sentiment regarding the company's future performance. Market reactions may follow, reflecting investor concerns or confidence based on insider trading activity. The volume of shares traded is not specified in this report.
Read More: Edwards Lifesciences (EW) CFO Ullem sells $1M in company sharesMore Health Care stocks
Frequently asked questions
Is Edwards Lifesciences in the S&P 500?
Yes. Edwards Lifesciences (EW) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is EW in?
Edwards Lifesciences is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest EW news?
This page collects recent Edwards Lifesciences (EW) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is Edwards Lifesciences's stock price?
As of the most recent market data, Edwards Lifesciences (EW) traded at approximately $91.11. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is Edwards Lifesciences's market cap?
Edwards Lifesciences has a market capitalization of roughly $52.52B, based on its most recent share price and shares outstanding.
What is EW's P/E ratio?
EW trades at a trailing price-to-earnings ratio of about 54.2. The P/E ratio compares a company's share price to its earnings per share.